27 April 2010

ProteinLogic announces successful identification of ImmiPrint™ signatures for several new diseases. (click for detail)

24 March 2009

ProteinLogic closes Private Placing (click for detail)

30 September 2008

ProteinLogic announces collaboration with the Immune Tolerance Network (click for detail)

02 July 2008

ProteinLogic patent granted by Australian Patent Office (click for detail)

17 June 2008

Diagnostic testing method deemed patentable by Australian Patent Office (click for detail)

28 March 2008

ProteinLogic files new patent application for its Acute Myeloid Leukemia diagnostic test with the United States Patent and Trademark Office (USPTO)

24 January 2008

Notice of ProteinLogic Australian Patent Application advertised in the Official Journal of Patents

04 November 2007

ProteinLogic recruits Richard Cumming, former Global Marketing Director GE Healthcare as Head of Marketing

15 September 2007

ProteinLogic obtains early proof of principle for Acute Myeloid Leukemia (AML)